National Institute of Neurological Disorders and Stroke (NINDS) [clinicaltrials_resource:b453c0b0ddc9ae5ba2b7b2501a3f96f8]
John D Heiss, M.D. [clinicaltrials_resource:032df682d77c433e898b022a2a3adf98]William H Theodore, M.D. [clinicaltrials_resource:04c32ebfdca4f9b20195c237d0818b21]Tanya J Lehky, M.D. [clinicaltrials_resource:06bdbe308b9bd46269435834dbbe8017]Carine W Maurer, M.D. [clinicaltrials_resource:06e64815b50865c1a1f73788f50bf5da]Sandra B Martin [clinicaltrials_resource:09d48bcca10394995a4b3cf0e24795c8]Carsten G Bonnemann, M.D. [clinicaltrials_resource:0b406550a3cd9de913793f38dfb63563]Ami K Mankodi, M.D. [clinicaltrials_resource:0dcd02caea8a52550f25a0b6edbe350e]Ellen Sidransky, M.D. [clinicaltrials_resource:0e1dfb552e2c4446a7fb18ac7def21c1]Beth A Belluscio, M.D. [clinicaltrials_resource:108fab070206cc7444acb8a615342b2d]Mary Kay Floeter, M.D. [clinicaltrials_resource:154af79942e6d3a0c1b0698a516918b8]Eric M Wassermann, M.D. [clinicaltrials_resource:187b8f0b5bfc9b8b2116fd895bc8cac6]Avindra Nath, M.D. [clinicaltrials_resource:18ecce14d5689150107f38213ca394eb]Mark Hallett, M.D. [clinicaltrials_resource:23148ff82ff197fc22f97608cfd697b4]Ami K Mankodi, M.D. [clinicaltrials_resource:23776e8258e7d07d31400843e48467bc]Leonardo G Cohen, M.D. [clinicaltrials_resource:264ecd80205001f7c5c269f9d1d26493]Sara K Inati, M.D. [clinicaltrials_resource:2f9c70d4330e2de16438795833c112ab]Alan P. Koretsky, Ph.D. [clinicaltrials_resource:3031bc813729278aa97d694e8069ff85]Codrin I Lungu, M.D. [clinicaltrials_resource:34815b1283df304abaa927b4d956e320]Irene H Dustin, C.R.N.P. [clinicaltrials_resource:37c43688710af6f13beff9c7e2244980]Lawrence Latour, Ph.D. [clinicaltrials_resource:3acc21c3c420f93e0b039a03bd2b952e]Mark Hallett, M.D. [clinicaltrials_resource:3f4f69a790d71957d28a311df20aa9e9]Barbara I Karp, M.D. [clinicaltrials_resource:3f900434cf55d5940e2bd67e36a7bda6]Leonardo G Cohen, M.D. [clinicaltrials_resource:41ca17f62bb92844d23e511db75ebeb7]Avindra Nath, M.D. [clinicaltrials_resource:42430c6d85e3962c057f6f545e4c9cc2]Irene H Dustin, C.R.N.P. [clinicaltrials_resource:425a8138d738f819009a68efbb574d0e]Eric M Wassermann, M.D. [clinicaltrials_resource:42963f9a544708120aeb61918657a850]Eric M Wassermann, M.D. [clinicaltrials_resource:47f20ff35218581d6980aa6f038e8555]Ami K Mankodi, M.D. [clinicaltrials_resource:49f8f3a91aafa2dff084b845dd7d284b]John D Heiss, M.D. [clinicaltrials_resource:595a4dbb20a216c6193655cca34bf398]Biyu J He, Ph.D. [clinicaltrials_resource:599dd1d949938eeecf908c5fc8ee9e95]Kenneth H Fischbeck, M.D. [clinicaltrials_resource:5a397aed5a07e31f85d7cfb4bd8bab2e]Bibiana Bielekova, M.D. [clinicaltrials_resource:5c06a52267fef62fe7d6a5d1b80ea307]Carsten G Bonnemann, M.D. [clinicaltrials_resource:5da2d39335f342c1172102e2dd85f944]Minal J Bhanushali, M.D. [clinicaltrials_resource:5ebac77aeffc8c5cb1dcaf5b31afe6fe]Kenneth H Fischbeck, M.D. [clinicaltrials_resource:660b86279ae5bba823915703f5065a0d]Avindra Nath, M.D. [clinicaltrials_resource:674f596b23c70bd8c759c99240e3ca4e]Carine W Maurer, M.D. [clinicaltrials_resource:69f4c67bd3236752cf955232dfa89651]Alan P. Koretsky, Ph.D. [clinicaltrials_resource:6a18115f39f8557db20f246c76139a36]Kareem A Zaghloul, M.D. [clinicaltrials_resource:6ad7631bfcd61c7f886a1b2dead0a058]William H Theodore, M.D. [clinicaltrials_resource:6c0cacddd13b2fa3930fdbe505a5cf7c]
affiliation [clinicaltrials_vocabulary:affiliation]
Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome [clinicaltrials:NCT00004274]Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome [clinicaltrials:NCT00004275]Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus [clinicaltrials:NCT00004297]Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes [clinicaltrials:NCT00004351]Determinants of Disease Severity in Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00004457]Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone [clinicaltrials:NCT00004645]Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors [clinicaltrials:NCT00004659]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis [clinicaltrials:NCT00004744]Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia [clinicaltrials:NCT00004751]Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury [clinicaltrials:NCT00004759]Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury [clinicaltrials:NCT00004812]Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures [clinicaltrials:NCT00004817]Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease [clinicaltrials:NCT00004844]Registry of Fabry Disease - A Multicenter Observational Study [clinicaltrials:NCT00055016]Moving a Paralyzed Hand Through Use of a Brain-Computer Interface [clinicaltrials:NCT00242242]Long-Term Improvement in Motor Learning by Transcranial Direct Current Stimulation [clinicaltrials:NCT00314769]Measuring Blood Flow in the Brain [clinicaltrials:NCT00466934]Warfighter Head Injury Study [clinicaltrials:NCT00754169]Effect of Reward on Learning in Motor Cortex [clinicaltrials:NCT00885131]clinicaltrials:NCT00942851Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury [clinicaltrials:NCT01132937]Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury [clinicaltrials:NCT01194661]Structural and Functional Neuroimaging Studies of Combat Veterans [clinicaltrials:NCT01296126]Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement Disorders [clinicaltrials:NCT01485263]The Effects of Chronic Exposure to Low-Level Blasts [clinicaltrials:NCT01524822]clinicaltrials:NCT01798888Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation [clinicaltrials:NCT01925196]Depotentiation in People With Focal Hand Dystonia [clinicaltrials:NCT02106936]Neural Basis of Decision-Making Deficits in Traumatic Brain Injury [clinicaltrials:NCT02169310]Variability of Molecular Biomarkers and Clinical Measures in People With Myotonic Dystrophy Type 1 [clinicaltrials:NCT02176798]
collaborator [clinicaltrials_vocabulary:collaborator]
Blood Sampling for Neurochemical and Genetic Testing [clinicaltrials:NCT00001147]Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]Monitoring Patients With Uncontrolled Epilepsy [clinicaltrials:NCT00001149]Assessment of Patients With Multiple Sclerosis (MS) [clinicaltrials:NCT00001156]Evaluation of Factors in Human Brain Tumors [clinicaltrials:NCT00001171]Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders [clinicaltrials:NCT00001178]Study of "Post-Polio Syndrome" [clinicaltrials:NCT00001185]Evaluation of Neuromuscular Disease [clinicaltrials:NCT00001201]Botulinum Toxin for the Treatment of Involuntary Movement Disorders [clinicaltrials:NCT00001208]Non-Invasive Electrical Stimulation of the Human Brain [clinicaltrials:NCT00001216]Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells [clinicaltrials:NCT00001234]Genetic Studies in Alzheimer's Disease [clinicaltrials:NCT00001235]Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS) [clinicaltrials:NCT00001248]Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies [clinicaltrials:NCT00001261]Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [clinicaltrials:NCT00001287]Brain Blood Flow Studies of Language and Memory [clinicaltrials:NCT00001288]Effects of Enzyme Replacement in Gaucher's Disease [clinicaltrials:NCT00001289]PET Scan to Study Brain Control of Human Movement [clinicaltrials:NCT00001324]Metabolic Abnormalities in Children With Epilepsy [clinicaltrials:NCT00001325]Establishing the Physiology of Syringomyelia [clinicaltrials:NCT00001327]Gene Therapy for the Treatment of Brain Tumors [clinicaltrials:NCT00001328]Study of Norepinephrine Levels and Sympathetic Nervous System Activity [clinicaltrials:NCT00001329]Magnetic Resonance Imaging Studies of Motor and Thought Processes [clinicaltrials:NCT00001361]Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders [clinicaltrials:NCT00001362]PET Scan to Map the Areas of the Brain Involved in Planning [clinicaltrials:NCT00001363]Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities [clinicaltrials:NCT00001364]Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System [clinicaltrials:NCT00001365]Mapping the Areas of the Brain Associated With Language in Children With Epilepsy [clinicaltrials:NCT00001366]Diagnosis and History Study of Patients With Different Neurological Conditions [clinicaltrials:NCT00001367]Potential Risk Factors for Stroke [clinicaltrials:NCT00001368]Bone Response to Enzyme Replacement in Gaucher's Disease [clinicaltrials:NCT00001416]Direct Injection of Alcohol for the Treatment of Spinal Tumors [clinicaltrials:NCT00001417]PET Scan in Patients With Neurocardiologic Disorders [clinicaltrials:NCT00001418]Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism [clinicaltrials:NCT00001489]Analysis of the Nervous System in Patients With Fabry's Disease [clinicaltrials:NCT00001491]Diagnosis and Natural History Study of Patients With Neurological Conditions [clinicaltrials:NCT00001549]Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) [clinicaltrials:NCT00001550]Characteristics of Idiopathic Familial Speech Disorders [clinicaltrials:NCT00001551]Characteristics of Idiopathic Familial Voice Disorders [clinicaltrials:NCT00001552]Motor Changes Associated With Recovery From Stroke After Therapy [clinicaltrials:NCT00001553]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Antiplatelet Therapy to Prevent Stroke in African Americans [clinicaltrials:NCT00004727]Aspirin Or Warfarin To Prevent Stroke [clinicaltrials:NCT00004728]Ketogenic Diet for Child Epilepsy and Seizure Control [clinicaltrials:NCT00004729]Parkinson's Disease Treatment With Coenzyme Q10 [clinicaltrials:NCT00004731]Timing of Levodopa Treatment in Parkinson's Disease [clinicaltrials:NCT00004733]Vitamin Therapy for Prevention of Stroke [clinicaltrials:NCT00004734]Women's Estrogen for Stroke Trial (WEST) [clinicaltrials:NCT00026039]Hormone Replacement in Menopausal Women With Epilepsy [clinicaltrials:NCT00027209]Hypothermia During Intracranial Aneurysm Surgery Trial [clinicaltrials:NCT00029133]Efficacy of a Family Telephone Intervention for Stroke [clinicaltrials:NCT00031265]Treatment of AIDS Vacuolar Myelopathy With Methionine [clinicaltrials:NCT00032695]Brain Imaging and Retreatment Study of Persistent Lyme Disease [clinicaltrials:NCT00037479]Families In Recovery From Stroke Trial (F.I.R.S.T.) [clinicaltrials:NCT00037492]Theory-Based Interventions for Smoking and Obesity (Challenge) Trial [clinicaltrials:NCT00040287]Hypothermia to Treat Severe Brain Injury [clinicaltrials:NCT00040339]Minocycline to Treat Amyotrophic Lateral Sclerosis [clinicaltrials:NCT00047723]Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial [clinicaltrials:NCT00059319]Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV) [clinicaltrials:NCT00116558]A Pilot Study of Neurocysticercosis Treatment [clinicaltrials:NCT00283699]
source [clinicaltrials_vocabulary:source]
National Institute of Neurological Disorders and Stroke (NINDS) [clinicaltrials_resource:b453c0b0ddc9ae5ba2b7b2501a3f96f8]
Bio2RDF identifier
b453c0b0ddc9ae5ba2b7b2501a3f96f8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b453c0b0ddc9ae5ba2b7b2501a3f96f8
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:b453c0b0ddc9ae5ba2b7b2501a3f96f8
title
National Institute of Neurological Disorders and Stroke (NINDS)
@en
type
label
National Institute of Neurolog ...... 3c0b0ddc9ae5ba2b7b2501a3f96f8]
@en